The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
Primary Purpose
Hypertension
Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Amlodipine and Hydrocholorothiazide
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- mild hypertension and high cholesterol
Exclusion Criteria:
- diabetes and heart disease
Sites / Locations
- UNMHSC
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
1
2
Arm Description
Amlodipine
HCTZ
Outcomes
Primary Outcome Measures
PAI-1
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00656331
Brief Title
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
Official Title
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications: A Comparison of Amlodipine and Hydrochlorothiazide
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Withdrawn
Study Start Date
August 2005 (undefined)
Primary Completion Date
June 2012 (Actual)
Study Completion Date
June 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of New Mexico
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to compare the effects of the cholesterol medication taken with each blood pressure medication alone on heart disease risk factors including blood pressure, cholesterol, inflammation, blood sugar control, blood vessal function, and other heart disease risk factors.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Active Comparator
Arm Description
Amlodipine
Arm Title
2
Arm Type
Active Comparator
Arm Description
HCTZ
Intervention Type
Drug
Intervention Name(s)
Amlodipine and Hydrocholorothiazide
Intervention Description
Arm 1 gets Amlodipine and Arm 2 gets Hydrocholorothiazide
Primary Outcome Measure Information:
Title
PAI-1
Time Frame
study completion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
mild hypertension and high cholesterol
Exclusion Criteria:
diabetes and heart disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kathleen Colleran, MD
Organizational Affiliation
University of New Mexico
Official's Role
Principal Investigator
Facility Information:
Facility Name
UNMHSC
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87131
Country
United States
12. IPD Sharing Statement
Learn more about this trial
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
We'll reach out to this number within 24 hrs